Radicava Approved to Treat Amyotrophic Lateral Sclerosis
Radicava, given intravenously, slows physical decline in patients with ALS.
Radicava, given intravenously, slows physical decline in patients with ALS.
Certain types of seafood may be linked to the disease, early research suggests.
Study shows that a higher intake of antioxidants and carotenes from vegetables is tied to a better ALS functional rating score.
The latest breakthrough in amyotrophic lateral sclerosis (ALS) research recently came out of Israel after a leading developer of adult stem cell technologies for neurodegenerative diseases announced positive results from a clinical trial of a potential treatment.